
    
      Single arm, prospective, multi-center feasibility study enrolling up to 48 subjects with
      atherosclerotic lesions in the infrapopliteal arteries and/or Critical Limb Ischemia (CLI).
      The study will capture acute angiographic data to compare the pre-SerranatorÂ® inflation vs
      post inflation effects and will include 6 month clinical follow up.

      The study population will consist of subjects with claudication or CLI, with de novo stenoses
      or non-stented restenotic or total occlusion lesions in infrapopliteal arteries having lesion
      length up to and including 12 cm in length and reference vessel diameter of 2.5 mm to 3.5 mm
      inclusive.
    
  